Inactive Instrument
Ocata Therapeutics Inc Stock
Stocks
US67457L1008
Biotechnology & Medical Research
|
End-of-day quote
Nasdaq
|
||
| - USD | - |
|
| Manager | Title | Age | Since |
|---|---|---|---|
John Heffernan
PRN | Corporate Officer/Principal | - | 03/02/2015 |
| Director | Title | Age | Since |
|---|---|---|---|
Toru Yoshimitsu
BRD | Director/Board Member | 63 | - |
Masaaki Hirano
BRD | Director/Board Member | 59 | - |
| Director/Board Member | 53 | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +4.16% | +3.04% | +49.37% | +94.17% | 74.16B | |
| -0.37% | -3.88% | +19.75% | +78.35% | 57.39B | |
| +1.63% | +0.98% | +3.83% | +38.21% | 47.64B | |
| +0.50% | +2.94% | +345.86% | +722.17% | 44.29B | |
| +3.05% | -1.80% | +29.79% | +34.51% | 42.5B | |
| +1.00% | -1.46% | +4.97% | +111.90% | 40.71B | |
| -0.54% | +2.93% | +9.31% | +54.06% | 30.97B | |
| +1.56% | +4.53% | +31.34% | +26.92% | 28.53B | |
| +0.76% | -1.45% | -7.15% | -11.12% | 24.34B | |
| Average | +1.28% | -0.59% | +54.12% | +127.69% | 43.39B | |
| Weighted average by Cap. | +1.52% | -0.84% | +58.31% | +136.94% |
- Stock Market
- Stocks
- Stock
Select your edition
All financial news and data tailored to specific country editions
